Literature DB >> 21569068

First-line treatments for hepatitis C.

A Messori, F Del Santo, D Maratea.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21569068     DOI： 10.1111/j.1365-2036.2011.04672.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.

Authors:  Fabiola Del Santo; Dario Maratea; Valeria Fadda; Sabrina Trippoli; Andrea Messori
Journal:  Eur J Clin Pharmacol       Date:  2011-11-05       Impact factor: 2.953

2.  Effect of discounting on estimation of benefits determined by hepatitis C treatment.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 3.  Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.

Authors:  Ya-Wu Zhang; Yu-Long Zhang; Hui Pan; Feng-Xian Wei; You-Cheng Zhang; Yuan Shao; Wei Han; Hai-Peng Liu; Zhe-Yuan Wang; Sun-Hu Yang
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.